Evidence map›Paper›PMID 39747086›Full record

ArticleNature communications2025

TransLeish: Identification of membrane transporters essential for survival of intracellular Leishmania parasites in a systematic gene deletion screen.

Andreia Albuquerque-Wendt, Ciaran McCoy, Rachel Neish, Ulrich Dobramysl, Çağla Alagöz, Tom Beneke, Sally A Cowley, Kathryn Crouch, Richard J Wheeler, Jeremy C Mottram and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Frontiers in immunology · 2026
    Review
  7. Article
  8. CRISPR-Cas13b mediated gene knockdowns in Leishmania infantum.International journal for parasitology. Drugs and drug resistance · 2025
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andreia Albuquerque-WendtSchool of Infection and Immunity, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow, G12 8TA, UK.
Ciaran McCoyUniversity of Oxford, Sir William Dunn School of Pathology, South Parks Road, Oxford, OX1 3RE, UK.
Rachel NeishYork Biomedical Research Institute, Department of Biology, University of York, York, YO10 5DD, UK.ORCID 0000-0001-9756-546X
Ulrich DobramyslMedawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-9363-654X
Çağla AlagözInstitute of Cell Biology, University of Bern, Baltzerstrasse 4, 3012, Bern, Switzerland.
Tom BenekeUniversity of Oxford, Sir William Dunn School of Pathology, South Parks Road, Oxford, OX1 3RE, UK.ORCID 0000-0001-9117-2649
Sally A CowleyJames and Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.ORCID 0000-0003-0297-6675
Kathryn CrouchSchool of Infection and Immunity, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow, G12 8TA, UK.ORCID 0000-0001-9310-4762
Richard J WheelerMedawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-4270-8360
Jeremy C MottramYork Biomedical Research Institute, Department of Biology, University of York, York, YO10 5DD, UK.ORCID 0000-0001-5574-3766
Eva GluenzSchool of Infection and Immunity, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow, G12 8TA, UK. eva.gluenz@unibe.ch.ORCID 0000-0003-4346-8896

Funding

EC | EC Seventh Framework Programm | FP7 People: Marie-Curie Actions (FP7-PEOPLE - Specific Programme "People" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) trans-LEISHion-EU FP7, No. 798736EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 101064428 - LeishMOMEuropean Molecular Biology Organization (EMBO) ALTF 727-2021Medical Research Council MR/R000859/1Medical Research Council MR/R000859/2Medical Research Council MR/V000446/1RCUK | Medical Research Council (MRC) 15/16_MSD_836338Royal Society UF160661Wellcome TrustWellcome Trust (Wellcome) 104111/Z/14/ZWellcome Trust (Wellcome) 200807/Z/16/ZWellcome Trust (Wellcome) 211075/Z/18/ZWellcome Trust (Wellcome) 221944/A/20/Z
6 · The paper itself

Abstract

For the protozoan parasite Leishmania, completion of its life cycle requires sequential adaptation of cellular physiology and nutrient scavenging mechanisms to the different environments of a sand fly alimentary tract and the acidic mammalian host cell phagolysosome. Transmembrane transporters are the gatekeepers of intracellular environments, controlling the flux of solutes and ions across membranes. To discover which transporters are vital for survival as intracellular amastigote forms, we carried out a systematic loss-of-function screen of the L. mexicana transportome. A total of 312 protein components of small molecule carriers, ion channels and pumps were identified and targeted in a CRISPR-Cas9 gene deletion screen in the promastigote form, yielding 188 viable null mutants. Forty transporter deletions caused significant loss of fitness in macrophage and mouse infections. A striking example is the Vacuolar H

Indexed as

CRISPR-Cas SystemsGene DeletionMacrophagesMembrane Transport ProteinsProtozoan ProteinsAnimalsFemaleLeishmania mexicanaMiceMice, Inbred BALB CVacuolar Proton-Translocating ATPasesMembrane Transport ProteinsProtozoan ProteinsVacuolar Proton-Translocating ATPases

Identifiers

PMID39747086
PMCPMC11696137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.